Healthcare of Ontario Pension Plan Trust Fund Purchases 8,123 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) by 10.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,714 shares of the construction company’s stock after buying an additional 8,123 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Aspen Aerogels were worth $2,456,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Driehaus Capital Management LLC grew its stake in shares of Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after acquiring an additional 1,220,724 shares in the last quarter. FMR LLC boosted its holdings in Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after purchasing an additional 773,647 shares during the last quarter. American Century Companies Inc. grew its position in Aspen Aerogels by 562.3% in the second quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after purchasing an additional 654,350 shares in the last quarter. Millennium Management LLC acquired a new stake in Aspen Aerogels in the 2nd quarter valued at $9,339,000. Finally, Renaissance Technologies LLC bought a new stake in Aspen Aerogels during the 2nd quarter worth about $8,340,000. 97.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on ASPN. Roth Mkm decreased their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research note on Tuesday, August 20th. Barclays dropped their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Finally, Benchmark restated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $28.70.

Check Out Our Latest Analysis on ASPN

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Price Performance

Shares of ASPN opened at $14.80 on Friday. The firm has a market capitalization of $1.21 billion, a PE ratio of 1,480.00 and a beta of 2.21. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company’s 50-day moving average is $19.94 and its 200-day moving average is $23.91. Aspen Aerogels, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $33.15.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Stories

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.